The new worry is the new variant of coronavirus, omicron. The Indian government has kicked off new travel protocols on December 1. This spells higher volumes for diagnostic labs.While sharing their views, Dr Om Manchanda, Managing Director at Dr Lal Pathlabs and Ameera Shah, Promoter and Managing Director at Metropolis Healthcare said that they don’t see huge upside due to these regulations on travel.COVID testing since the month of July has seen a sharp downward correction.Also Read: Omicron: Travelling between India and Europe? Key things to knowAmeera Shah believes the clarity on omicron will emerge in another few weeks.According to her, the current testing kits, which are in use, might become irrelevant as it might fail to find the S gene to detect the omicron variant. Unfortunately, it means the higher number of false negatives in the short run till potentially chemical kits will be ready to find it more accurately.For the full interview, watch the accompanying video.Catch all market updates here.